<VariationArchive RecordType="classified" VariationID="31542" VariationName="NM_001099274.3(TINF2):c.839del (p.Lys280fs)" VariationType="Deletion" Accession="VCV000031542" Version="2" NumberOfSubmissions="1" NumberOfSubmitters="1" DateLastUpdated="2023-03-18" DateCreated="2013-09-19" MostRecentSubmission="2023-03-18">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="40214" VariationID="31542">
      <GeneList>
        <Gene Symbol="TINF2" FullName="TERF1 interacting nuclear factor 2" GeneID="26277" HGNC_ID="HGNC:11824" Source="submitted" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>14q12</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="14" Accession="NC_000014.9" start="24239640" stop="24242674" display_start="24239640" display_stop="24242674" Strand="-" />
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="14" Accession="NW_018654722.1" start="540618" stop="543652" display_start="540618" display_stop="543652" Strand="-" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="14" Accession="NC_000014.8" start="24708848" stop="24711879" display_start="24708848" display_stop="24711879" Strand="-" />
          </Location>
          <OMIM>604319</OMIM>
        </Gene>
      </GeneList>
      <Name>NM_001099274.3(TINF2):c.839del (p.Lys280fs)</Name>
      <CanonicalSPDI>NC_000014.9:24240640:TT:T</CanonicalSPDI>
      <VariantType>Deletion</VariantType>
      <Location>
        <CytogeneticLocation>14q12</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="14" Accession="NC_000014.9" start="24240641" stop="24240641" display_start="24240641" display_stop="24240641" variantLength="1" positionVCF="24240640" referenceAlleleVCF="CT" alternateAlleleVCF="C" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="14" Accession="NC_000014.8" start="24709847" stop="24709847" display_start="24709847" display_stop="24709847" variantLength="1" positionVCF="24709846" referenceAlleleVCF="CT" alternateAlleleVCF="C" />
      </Location>
      <ProteinChange>K245fs</ProteinChange>
      <ProteinChange>K280fs</ProteinChange>
      <HGVSlist>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="LRG_342" sequenceAccession="LRG_342">
            <Expression>LRG_342:g.7034del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="LRG_342t1" sequenceAccession="LRG_342t1">
            <Expression>LRG_342t1:c.839del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="LRG_342p1" sequenceAccession="LRG_342p1" change="p.Lys280fs">
            <Expression>LRG_342p1:p.Lys280fs</Expression>
          </ProteinExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="LRG_342t2" sequenceAccession="LRG_342t2">
            <Expression>LRG_342t2:c.839del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="LRG_342p2" sequenceAccession="LRG_342p2" change="p.Lys280fs">
            <Expression>LRG_342p2:p.Lys280fs</Expression>
          </ProteinExpression>
        </HGVS>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000014.8" sequenceAccession="NC_000014" sequenceVersion="8" change="g.24709848del" Assembly="GRCh37">
            <Expression>NC_000014.8:g.24709848del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000014.9" sequenceAccession="NC_000014" sequenceVersion="9" change="g.24240642del" Assembly="GRCh38">
            <Expression>NC_000014.9:g.24240642del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_016650.1" sequenceAccession="NG_016650" sequenceVersion="1" change="g.7034del">
            <Expression>NG_016650.1:g.7034del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_054634.1" sequenceAccession="NG_054634" sequenceVersion="1" change="g.13226del">
            <Expression>NG_054634.1:g.13226del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001099274.3" sequenceAccession="NM_001099274" sequenceVersion="3" change="c.839del" MANESelect="true">
            <Expression>NM_001099274.3:c.839del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001092744.1" sequenceAccession="NP_001092744" sequenceVersion="1" change="p.Lys280fs">
            <Expression>NP_001092744.1:p.Lys280fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001363668.2" sequenceAccession="NM_001363668" sequenceVersion="2" change="c.734del">
            <Expression>NM_001363668.2:c.734del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001350597.1" sequenceAccession="NP_001350597" sequenceVersion="1" change="p.Lys245fs">
            <Expression>NP_001350597.1:p.Lys245fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_012461.3" sequenceAccession="NM_012461" sequenceVersion="3" change="c.839del">
            <Expression>NM_012461.3:c.839del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_036593.2" sequenceAccession="NP_036593" sequenceVersion="2" change="p.Lys280fs">
            <Expression>NP_036593.2:p.Lys280fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
      </HGVSlist>
      <XRefList>
        <XRef Type="Allelic variant" ID="604319.0006" DB="OMIM" />
        <XRef Type="rs" ID="1594551449" DB="dbSNP" />
      </XRefList>
      <Comment DataSource="ClinGen" Type="public">ClinGen staff contributed the HGVS expression for this variant.</Comment>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_001099274.3(TINF2):c.839del (p.Lys280fs) AND Revesz syndrome" Accession="RCV000024249" Version="4">
        <ClassifiedConditionList TraitSetID="1584">
          <ClassifiedCondition DB="MedGen" ID="C1327916">Revesz syndrome</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>no assertion criteria provided</ReviewStatus>
            <Description DateLastEvaluated="2012-05-01" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2012-05-01" NumberOfSubmissions="1" NumberOfSubmitters="1" DateCreated="2013-09-19" MostRecentSubmission="2023-03-18">
        <ReviewStatus>no assertion criteria provided</ReviewStatus>
        <Description>Pathogenic</Description>
        <Citation Type="general">
          <ID Source="PubMed">21477109</ID>
        </Citation>
        <ConditionList>
          <TraitSet ID="1584" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="4350" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">Exudative retinopathy with bone marrow failure</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">DYSKERATOSIS CONGENITA, AUTOSOMAL DOMINANT 5</ElementValue>
                <XRef Type="MIM" ID="268130" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Preferred">Revesz syndrome</ElementValue>
                <XRef ID="Revesz+syndrome/6295" DB="Genetic Alliance" />
                <XRef ID="MONDO:0009990" DB="MONDO" />
              </Name>
              <Symbol>
                <ElementValue Type="Alternate">DKCA5</ElementValue>
                <XRef Type="MIM" ID="268130" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="4695" />
                <XRef ID="4695" DB="Office of Rare Diseases" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="public definition">Dyskeratosis congenita and related telomere biology disorders (DC/TBD) are caused by impaired telomere maintenance resulting in short or very short telomeres. The phenotypic spectrum of telomere biology disorders is broad and includes individuals with classic dyskeratosis congenita (DC) as well as those with very short telomeres and an isolated physical finding. Classic DC is characterized by a triad of dysplastic nails, lacy reticular pigmentation of the upper chest and/or neck, and oral leukoplakia, although this may not be present in all individuals. People with DC/TBD are at increased risk for progressive bone marrow failure (BMF), myelodysplastic syndrome or acute myelogenous leukemia, solid tumors (usually squamous cell carcinoma of the head/neck or anogenital cancer), and pulmonary fibrosis. Other findings can include eye abnormalities (epiphora, blepharitis, sparse eyelashes, ectropion, entropion, trichiasis), taurodontism, liver disease, gastrointestinal telangiectasias, and avascular necrosis of the hips or shoulders. Although most persons with DC/TBD have normal psychomotor development and normal neurologic function, significant developmental delay is present in both forms; additional findings include cerebellar hypoplasia (Hoyeraal Hreidarsson syndrome) and bilateral exudative retinopathy and intracranial calcifications (Revesz syndrome and Coats plus syndrome). Onset and progression of manifestations of DC/TBD vary: at the mild end of the spectrum are those who have only minimal physical findings with normal bone marrow function, and at the severe end are those who have the diagnostic triad and early-onset BMF.</Attribute>
                <XRef ID="NBK22301" DB="GeneReviews" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301779</ID>
                <ID Source="BookShelf">NBK22301</ID>
              </Citation>
              <XRef ID="3088" DB="Orphanet" />
              <XRef ID="C1327916" DB="MedGen" />
              <XRef ID="MONDO:0009990" DB="MONDO" />
              <XRef Type="MIM" ID="268130" DB="OMIM" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="50800" SubmissionDate="2013-09-17" DateLastUpdated="2023-03-18" DateCreated="2013-04-04">
        <ClinVarSubmissionID localKey="604319.0006_REVESZ SYNDROME" title="TINF2, 1-BP DEL, 839A_REVESZ SYNDROME" />
        <ClinVarAccession Accession="SCV000045540" DateUpdated="2023-03-18" DateCreated="2013-04-04" Type="SCV" Version="3" SubmitterName="OMIM" OrgID="3" OrganizationCategory="resource" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2012-05-01">
          <ReviewStatus>no assertion criteria provided</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species>human</Species>
              <AffectedStatus>not provided</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>literature only</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">In a 21-month-old Hispanic boy with Revesz syndrome (268130), Sasa et al. (2012) identified a heterozygous 1-bp deletion (839delA) in exon 6 of the TINF2 gene, resulting in a frameshift and premature termination. The mutation was not present in the mother, but the reportedly normal father was not available. The child presented with severe aplastic anemia and was noted to have bilateral exudative retinopathy at age 9 months. He also had poor growth, nail dystrophy, oral leukoplakia, and delayed development with wide-based gait, suggesting cerebellar involvement. He underwent cord blood transplantation, but died 92 days later. Telomere lengths were shortened. A truncated protein was expressed, but at lower levels than wildtype, suggesting decreased stability.</Attribute>
              <Citation>
                <ID Source="PubMed">21477109</ID>
              </Citation>
              <XRef DB="OMIM" ID="268130" Type="MIM" />
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="TINF2" />
          </GeneList>
          <Name>TINF2, 1-BP DEL, 839A</Name>
          <VariantType>Variation</VariantType>
          <OtherNameList>
            <Name Type="NonHGVS">1-BP DEL, 839A</Name>
          </OtherNameList>
          <XRefList>
            <XRef DB="OMIM" ID="604319.0006" Type="Allelic variant" />
          </XRefList>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">REVESZ SYNDROME</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="50800" TraitType="Disease" MappingType="Name" MappingValue="REVESZ SYNDROME" MappingRef="Preferred">
        <MedGen CUI="C1327916" Name="Revesz syndrome" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

